Positron emission tomography-computed tomography in the diagnostic evaluation of smoldering multiple myeloma: identification of patients needing therapy

Smoldering multiple myeloma

(2015) S. V. Rajkumar et al.   BLOOD

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

(2014) M Merz et al.   LEUKEMIA

Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review

(2013) Josien C. Regelink et al.   BRITISH JOURNAL OF HAEMATOLOGY

Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma

(2013) María-Victoria Mateos et al.   NEW ENGLAND JOURNAL OF MEDICINE

High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma

(2012) G Bianchi et al.   LEUKEMIA

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

(2012) J T Larsen et al.   LEUKEMIA

Redefining myeloma

(2012) S. Vincent Rajkumar et al.   Nature Reviews Clinical Oncology

Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

(2010) Jens Hillengass et al.   JOURNAL OF CLINICAL ONCOLOGY

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

(2010) R A Kyle et al.   LEUKEMIA

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

(2007) A. Dispenzieri et al.   BLOOD